Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 1 of 1 for:    XenoTherapeutics
Previous Study | Return to List | Next Study

Evaluation of Safety of Xeno-Skin™ for Treatment of Severe and Extensive, Partial and Full Thickness Burns

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03695939
Recruitment Status : Recruiting
First Posted : October 4, 2018
Last Update Posted : January 7, 2020
Massachusetts General Hospital
Information provided by (Responsible Party):
XenoTherapeutics, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : April 15, 2020
Estimated Study Completion Date : July 15, 2020
Fishman JA. Screening of source animals and clinical monitoring for xenotransplantation. Xenotransplantation. 2007, 349-352.
Herndon DN. Total Burn Care, Expert Consult - Online. Elsevier Health Sciences; 2012.
Organ Procurement and Transplantation Network. (n.d.). Retrieved May 01, 2017, from
Schaffer A. Cadaver Skin Fills the Gap in Burn Cases. New York Times. May 2, 2006.
Thorton JF and Gosman AA. Skin Grafts and Skin Substitutes. Baylor University Medical Center. 2004 10(1): 2-78
World Health Organization Burn Fact Sheet. March 6, 2018.